Presentation is loading. Please wait.

Presentation is loading. Please wait.

Understanding and influencing EU research policy Michael Wood, 26 February 2014.

Similar presentations

Presentation on theme: "Understanding and influencing EU research policy Michael Wood, 26 February 2014."— Presentation transcript:

1 Understanding and influencing EU research policy Michael Wood, 26 February 2014

2 NHS European Office Who are we? –Established 2007 –Part of the NHS Confederation –Funded by national NHS bodies What do we do? –Represent NHS organisations in EU policy-making and legislation –Assist the NHS with the implementation of EU law –Offer strategic advice on EU funding opportunities –Promote partnerships between NHS organisations and bodies from other sectors/countries.

3 EU funding - What we are doing to help The NHS European Office can assist NHS organisations wishing to apply for EU funds. We can: look at a project concept note and help assess whether it would be a potential fit for European funding support your organisation in establishing appropriate European partnerships help answer technical and administrative questions help develop capacity in your organisation to apply for and manage EU funds

4 Back to the future…

5 EU health research funding – how are we doing?

6 FP7 Health – where was the NHS? Strong acute/specialist focus BUT scope for more...

7 FP7 Health – where was the NHS? NHS thematic experience is broad, but reoccurring subjects: chronic conditions; such as cancer, heart conditions, diabetes clinical trials paediatrics Ageing, including ICT/eHealth mental health (including Dementia, Parkinson’s etc) Strong biomedical focus BUT scope for more...

8 My thoughts on NHS and FP7 Interest mainly confined to teaching hospitals and specialist providers Lack of real knowledge at NHS board level Clinical input often led through associated academic institutions Episodic interest on specific issues rather than wider focus on what matters for organisational strategy Limited appetite for the ‘long haul’ Even where NHS has been involved do we know about it? And yet NHS partners often actively sought across Europe

9 But benefits of collaboration are well known Participation in an EU-funded project can: complement local NHS initiatives with match-funding improve service delivery through information-sharing and exchange of good practice develop pan-European research networks benchmark and compare NHS practice with partners from other EU member states showcase the organisation’s achievements in a specific field or topic to international colleagues profile local, regional and national NHS innovations at international events attract world-class researchers to the organisation.

10 Looking ahead – the NHS and Horizon 2020 Number of reasons why scope for NHS engagement for 2014-2020 is greater than previously: Burning platform facing health and social care EU innovation agenda fits well with Innovation, Health and Wealth Greater focus in Horizon 2020 on commercialisation Horizon 2020 brings together several EU programmes and simplifies rules EC keen to bring wider range of stakeholders together – collaboration the key Inward investment critical to wealth creation agenda

11 Europeanising your research…

12 Why does the EU get involved in Research? It’s in the Treaty! But some things are not in the Treaty – need a complementary mix of legislation and funding Member States ask it to get involved EU competence in associated areas, for example EU Regulations and Directives on clinical trials, medical devices, data protection RTD role in jobs and growth critical for EU internal market It’s ultimately a global race - EU vs USA vs BRIC Commonly agreed area of EU added value and a respected Commission DG leading on it

13 Grounding Europe 2020 – the current strategy Europe 2020 10 year EU growth strategy employment; education; research and innovation; social inclusion and poverty reduction; and climate/energy Smart growth focused on knowledge and innovation Innovation Union improve conditions and access to finance for research and innovation in Europe, to ensure that innovative ideas can be turned into products and services that create growth and jobs investing 3% of EU GDP in R&D by 2020 Horizon 2020 financial instrument implementing the Innovation Union biggest EU Research and Innovation programme yet Also supports range of programmes, such as Marie Curie, IMI, AAL

14 Creating a European Research Area “A unified research area open to the world based on the Internal Market, in which researchers, scientific knowledge and technology circulate freely and through which the Union and its Member States strengthen their scientific and technological bases, their competitiveness and their capacity to collectively address grand challenges.” To be completed this year… ERA-NET funding

15 Regional Policy Systemic Innovation Concept Human Capital Market Knowledge Finance EIT- KICs research- industry- education Research funding Horizon2020 (focus on fundamental research, but also applied & innovation) ESIF Financial instruments ERDF, COSME, Horizon2020, CreativeEurope EIB i2i RTD&I state aid framework IPR & Communit y Patent Mobility ERASMUS+ Horizon: Marie Curie ESF Market replication projects Horizon SME instrument Linking up innovation actors pool / share knowledge, capacities & practice Skills ESF ERASMUS+ CreativeEurope Support services COSME: EEN, IPR helpdesk, Horizon Participants portal ESIF EURAXESS User-driven innovation LivingLabs (ERDF) Pooling public funds ERA-Nets, Art 185, JPIs, EIPs, EUREKA PPPs Art 187, JTI Infrastructure ERDF, Horizon2020, CEF digital ERA 5 th freedom 3% objective Modernising universities; qualification standards Sector / technology initiatives SET, nano-tech… EcoAP Eco-innov. Improve R&I policies & management RIS3, ETPs, EIPs "synchronisation" INTERREG Internal Market rules (finance, products, services …) Public procurement Directive Standar- disation Health & safety & eco regulations Access to global markets, trade Challenge driven innovation Horizon, ESIF, LIFE Policy initiative / legislation Action with funding Legend: User- centred innovation : design initiative ESFRI ERIC PCP & PPI Horizon2020, ESIF Social innovation ESF, EaSI, ERDF, Horizon2020 Innovation policy analysis (IUS, RIS, RIM, RIO, Cluster Observatory, …) EGTC

16 The long game…

17 What we see in public EU-funded project commences Collaborations reviewed and chosen EU calls for proposals launched Best possible outcome: A one-off success

18 What we see in public is just a fraction of what really happens Partners lobby for future EU funding for additional work EU-funded project commences Collaborations reviewed and chosen EU calls for proposals launched NCPs circulate draft calls for proposals Industry/groups call for focus in selected areas Extensive internal Commission working on areas to be funded and associated rules Best possible outcome: On-going success and influence

19 A competition for a competition Horizon 2020 is a significant, yet finite pot of money for 28 Member States and over 500 million people Many competing voices, all more important that the one before Never going to be a simple task to understand where its priorities should lie It’s (mostly) in the lobbying

20 All the EU Institutions are involved The European Commission –Initiates and reviews legislation/funding programmes –Many DGs, how well do they interact? The European Parliament –Co-legislatures with Council –c750 MEPs, only 73 from UK, and in groupings –Need to build alliances, target key MEPs Council of Ministers –Made up of national governments –Rarely the DH in Brussels representing UK govt

21 So it’s OK to lobby UK government lobbying Commission/Council for its priorities – but does the government know what it should be lobbying for? NCPs sit on Programme Management Committees – do they know what they should be lobbying for? MEPs sit on Parliamentary Committees – but do they know what they should be lobbying for? The priority areas chosen to be funded are not there by accident!

22 Who are the main actors doing the lobbying? NCPs National & regional governments Clinical groups Public health networks EU umbrella organisations Industry SMEs Institutions Charities Academics Patient reps Commission officials/MEPs themselves

23 Who are your NCPs? Dr Octavio Pernas Tel: 01302 322633 Twitter:@H2020_HealthNCP Alex Harris International Strategy Manager Medical Research Council Tel: 020 7395 2214

24 Early NCP intel

25 Where lobbying worked ECJ threat to stem cell research Concerns it would not feature in Horizon 2020 European campaign launched Joint statement from Wellcome Trust/AMRC/ EURORDIS/MRC/Swedish Research Council etc Focused on European Parliament Sir Mark Walport, Director Wellcome Trust, said: "The European Parliament must send a clear sign that it recognises the importance of embryonic stem cell research. While the amount of funding allocated to such research under Horizon 2020 is likely to be only a small portion of the overall budget, to close down such a vital avenue of research would be a massive blow to European science. It will significantly set back research into very serious diseases including Parkinson's and multiple sclerosis and is likely to cost European research its competitive advantage."

26 Strong thematic lobbying groups Rare Diseases Cancer Public Health eHealth Common factors –Strong parliamentary focus –EU wide umbrella groups –National actors engaged to spread messages within Member States –Link their issue into many different conversations

27 A way in – the European Innovation Partnership on Active and Healthy Ageing Non-funding, collaborative partnership scheme Range of stakeholders come together to foster innovations in products, processes and services for elderly people 31 European Reference sites approved –’testbeds’ for future EU-funded work Different way of doing things, with the EC as the facilitators, simply setting the parameters Punched outside of network of usual suspects Marketplace a great place to start Linked events/newsletter/policies /exchange of best practice

28 European Partners – finding a match Often toughest part of the puzzle – no exact science but critical to success – need to be aware of what you offer as a partner and what your consortium is missing Where to look? Existing networks/research/conversations/successful partners EIP AHA Marketplace & European Reference Sites

29 What then should we do…

30 Your starting point should not be Brussels Collaboration, Collaboration, Collaboration Domestic networking can provide a solid base EU funding offers opportunity for nationally funded projects to be elevated Existing contacts, combined knowledge Past projects, future opportunities AHSNs NIHR… Bring ‘Brussels’ in when you are clearer about your strategy

31 After the elections build relationships European Elections in May 2014, will lead to a new European Parliament. –Will any UK MEPs have a background in clinical research? New College of Commissioners to be appointed in the autumn –Who will be in charge of RTD? –Same secretariat but different advisors Relationship building period, before the legislative and non-legislative priorities are worked through Opportunity knocks…

32 Give the Commission what it wants Acknowledge there will always be the tricky balance between a transparent process of prioritising funding topics and a free-for-all – be smart The Commission has to be strategic in its approach, so should we (e.g. networks not institutions) The Commission wants to fund successful innovations that make an impact at a European level The Commission wants to fund projects that will contribute to its evidence base for future work The Commission wants to be able to say it has spent your money well

33 Top tips Be clear in your strategy about what you want to influence Set achievable goals, e.g. target the 2016-17 Horizon 2020 work programme Collaborate, around the issue and from the issue Understand the European history around your priority area – has it been funded previously? Have concerns been raised? Understand the full range of actors potentially involved Search out allies and use them in complementary fashion Draw up a common message that’s easily understood across audiences/sectors/borders Never assume Never stop!!

34 And shout about it!

35 So, you want to get involved? Sign up for our bulletin Keep an eye on our website Read our briefings Follow us on twitter Tell your colleagues! @NHSConfed_EU

Download ppt "Understanding and influencing EU research policy Michael Wood, 26 February 2014."

Similar presentations

Ads by Google